Medical Devices

Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, announces that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (“Danaher”) will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the “Transaction”). The Transaction has been unanimously approved by both Masimo’s Board

International private equity firm Cinven and Chicago-based Linden Capital Partners (‘Linden’) announce that Cinven has agreed to make a strategic investment in Regenity Biosciences (‘Regenity’ or ‘the Company’), a global developer and manufacturer of bioresorbable technologies and Linden portfolio company. Founded in 1997 and headquartered in New Jersey, USA, Regenity has spent nearly 30 years

Natus Sensory, a global leader in sensory and newborn care solutions, announces the acquisition of TheraB Medical, a medical technology company focused on advancing the treatment of neonatal jaundice through innovative, wearable phototherapy solutions. The acquisition strengthens Natus Sensory’s newborn care portfolio by expanding its phototherapy offering with the first FDA‑cleared wearable phototherapy system designed